Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32).
Brédart A, Bottomley A, Blazeby JM, Conroy T, Coens C, D'Haese S, Chie WC, Hammerlid E, Arraras JI, Efficace F, Rodary C, Schraub S, Costantini M, Costantini A, Joly F, Sezer O, Razavi D, Mehlitz M, Bielska-Lasota M, Aaronson NK; European Organisation for Research and Treatment of Cancer Quality of Life Group and Quality of Life Unit. Brédart A, et al. Among authors: rodary c. Eur J Cancer. 2005 Sep;41(14):2120-31. doi: 10.1016/j.ejca.2005.04.041. Eur J Cancer. 2005. PMID: 16182120
[Multisite validation study of questionnaire assessing out-patient satisfaction with care questionnaire in ambulatory chemotherapy or radiotherapy treatment].
Poinsot R, Altmeyer A, Conroy T, Savignoni A, Asselain B, Léonard I, Marx E, Cosquer M, Sévellec M, Gledhill J, Rodary C, Mercier M, Dickès P, Fabbro M, Antoine P, Guerif S, Schraub S, Dolbeault S, Brédart A. Poinsot R, et al. Among authors: rodary c. Bull Cancer. 2006 Mar 1;93(3):315-27. Bull Cancer. 2006. PMID: 16567319 Free article. French.
Determinants of patient satisfaction in oncology settings from European and Asian countries: preliminary results based on the EORTC IN-PATSAT32 questionnaire.
Brédart A, Coens C, Aaronson N, Chie WC, Efficace F, Conroy T, Blazeby JM, Hammerlid E, Costantini M, Joly F, Schraub S, Sezer O, Arraras JI, Rodary C, Costantini A, Mehlitz M, Razavi D, Bottomley A; EORTC Quality of Life Group and EORTC Quality of Life Unit. Brédart A, et al. Among authors: rodary c. Eur J Cancer. 2007 Jan;43(2):323-30. doi: 10.1016/j.ejca.2006.10.016. Epub 2006 Dec 6. Eur J Cancer. 2007. PMID: 17156997
Differential item functioning (DIF) in the EORTC QLQ-C30: a comparison of baseline, on-treatment and off-treatment data.
Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MA; EORTC Quality of Life Group and the Quality of Life Cross-Cultural Meta-Analysis Group. Scott NW, et al. Qual Life Res. 2009 Apr;18(3):381-8. doi: 10.1007/s11136-009-9453-7. Epub 2009 Feb 27. Qual Life Res. 2009. PMID: 19247808
Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.
Flamant F, Rodary C, Rey A, Praquin MT, Sommelet D, Quintana E, Theobald S, Brunat-Mentigny M, Otten J, Voûte PA, Habrand JL, Martelli H, Barrett A, Terrier-Lacombe MJ, Oberlin O. Flamant F, et al. Among authors: rodary c. Eur J Cancer. 1998 Jun;34(7):1050-62. doi: 10.1016/s0959-8049(98)00024-0. Eur J Cancer. 1998. PMID: 9849454 Clinical Trial.
62 results